Since LAP interference may “reprogram” the function of tumor-related macrophages to facilitate the clearance of cancer cells without interfering with typical autophagy processes, targeting LAP-specific proteins may be a potential therapeutic strategy. This evidence concerns the gene TGFB1 and neoplasm.